Publications by authors named "Terry Hermiston"

Claim this Profile
T
Targeted intracellular delivery of molecular cargo to hypoxic human breast cancer stem cells.
Ashley V Makela, Anthony Tundo, Huiping Liu, Doug Schneider, Terry Hermiston

Cancer Commun (Lond)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Divergent modulation of activated protein C pleiotropic functions by antibodies that differ by a single amino acid.
Derek S Sim, Meenal Shukla, Cornell R Mallari, José A Fernández, Xiao Xu, Terry W Hermiston

Blood Adv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted intracellular delivery of molecular cargo to hypoxic human breast cancer stem cells.
Ashley V Makela, Anthony Tundo, Huiping Liu, Doug Schneider, Terry Hermiston

bioRxiv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid clearing CT-001 restored hemostasis in mice with coagulopathy induced by activated protein C.
Derek S Sim, Cornell R Mallari, Maxine Bauzon, Terry W Hermiston

J Trauma Acute Care Surg· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CT-001, a novel fast-clearing factor VIIa, enhanced the hemostatic activity in postpartum samples.
Derek S Sim, Cornell R Mallari, Terry W Hermiston, Daekyeong Bae, Sul Lee

Blood Adv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gla-domain mediated targeting of externalized phosphatidylserine for intracellular delivery.
Jonathan Hardy, Maxine Bauzon, Charles Kwok Fai Chan, Ashley V Makela, Masamitsu Kanada, Terry Hermiston

FASEB J· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective modulation of activated protein C activities by a nonactive site-targeting nanobody library.
Derek S Sim, Meenal Shukla, Cornell R Mallari, José A Fernández, Xiao Xu, Terry W Hermiston

Blood Adv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphatidylserine-Exposing Annexin A1-Positive Extracellular Vesicles: Potential Cancer Biomarkers.
Gloria I Perez, Matthew P Bernard, Daniel Vocelle, Ahmed A Zarea, Najla A Saleh, Terry Hermiston

Vaccines (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CT-001 is a rapid clearing factor VIIa with enhanced clearance and hemostatic activity for the treatment of acute bleeding in non-hemophilia settings.
Derek S Sim, Cornell R Mallari, John M Teare, Maxine Bauzon, Terry W Hermiston

Thromb Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro characterization of CT-001-a short-acting factor VIIa with enhanced prohemostatic activity.
Derek S Sim, Cornell R Mallari, John M Teare, Richard I Feldman, Maxine Bauzon, Terry W Hermiston

Res Pract Thromb Haemost· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted inhibition of activated protein C by a non-active-site inhibitory antibody to treat hemophilia.
Xiao-Yan Zhao, Andreas Wilmen, Dongli Wang, Xinquan Wang, Maxine Bauzon, Terry Hermiston

Nat Commun· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus.
Sam Illingworth, Ying Di, Maxine Bauzon, Janet Lei, Margaret R Duffy, Terry Hermiston

Mol Ther Oncolytics· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators.
Arthur Dyer, Ying Di, Hugo Calderon, Sam Illingworth, Gray Kueberuwa, Terry Hermiston

Mol Ther Oncolytics· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OvAd1, a Novel, Potent, and Selective Chimeric Oncolytic Virus Developed for Ovarian Cancer by 3D-Directed Evolution.
Irene Kuhn, Maxine Bauzon, Nicola Green, Len Seymour, Kerry Fisher, Terry Hermiston

Mol Ther Oncolytics· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Armed therapeutic viruses - a disruptive therapy on the horizon of cancer immunotherapy.
Maxine Bauzon, Terry Hermiston

Front Immunol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global substrate profiling of proteases in human neutrophil extracellular traps reveals consensus motif predominantly contributed by elastase.
Anthony J O'Donoghue, Ye Jin, Giselle M Knudsen, Natascha C Perera, Dieter E Jenne, Terry W Hermiston

PLoS One· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancer.
Nicola K Green, Ashley Hale, Ryan Cawood, Sam Illingworth, Chris Herbert, Terry Hermiston

Nanomedicine (Lond)· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic viruses: the power of directed evolution.
Maxine Bauzon, Terry W Hermiston

Adv Virol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of different UCOE-promoter combinations in creation of engineered cell lines for the production of Factor VIII.
Ayyappan R Nair, Xie Jinger, Terry W Hermiston

BMC Res Notes· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic somatic cell therapy: process development challenges and future opportunities.
Farah S Fawaz, Terry W Hermiston, Harald Dinter

Curr Opin Mol Ther· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced protein production using HBV X protein (HBx), and synergy when used in combination with XBP1s in BHK21 cells.
Fang Jin, Peter J Kretschmer, Richard N Harkins, Terry W Hermiston

Biotechnol Bioeng· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rapid and efficient branched DNA hybridization assay to titer lentiviral vectors.
Ayyappan Nair, Jinger Xie, Sarasijam Joshi, Paul Harden, Joan Davies, Terry Hermiston

J Virol Methods· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting diversity: genetic approaches to creating highly potent and efficacious oncolytic viruses.
Maxine Bauzon, Terry W Hermiston

Curr Opin Mol Ther· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Directed evolution generates a novel oncolytic virus for the treatment of colon cancer.
Irene Kuhn, Paul Harden, Maxine Bauzon, Cecile Chartier, Julie Nye, Terry W Hermiston

PLoS One· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative study examining the cytotoxicity of inducible gene expression system ligands in different cell types.
Jinger Xie, Ayyappan Nair, Terry W Hermiston

Toxicol In Vitro· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis